In clinical validation · UK design partners welcome

Oral lesion triage built around clinician review.

OralPath is clinician-in-the-loop AI triage support for oral mucosal lesions. It is designed to help clinical teams review concerning presentations earlier while keeping responsibility and judgement with the clinician.

Clinician-in-the-loop Guideline-aware Clinician sign-off
Capture — structured case intake
1 / 4
OralPath capture screen: structured case intake
OralPath risk factors screen: smoking, alcohol, betel and HPV inputs
OralPath OMFS triage workstation: risk score and NICE NG12 red flags
OralPath service dashboard: throughput, triage outcomes and decision quality

Screens from the live OralPath build. Synthetic sample cohort only — no patient-identifiable information.

Features

Built for safer oral lesion review.

OralPath is designed as a clinician-controlled product experience, not a public specification. The page describes the clinical value and safety posture without exposing implementation detail.

NG

Guideline-aware safeguards

Safety boundaries are designed around recognised clinical review expectations without publishing internal logic.

Consistent clinical review

The product experience is designed to reduce variation in how relevant context is gathered and reviewed.

Clear review support

The interface is designed to make the support visible, challengeable and secondary to clinician judgement.

Clinician sign-off

Outputs remain under clinician control, with review and sign-off retained in the clinical workflow.

How it works

From case review to clinician sign-off.

The public workflow is deliberately high-level. Detailed product behaviour is not published on the open web.

  1. 01

    Review

    The clinician reviews the presenting context inside a guided product experience.

  2. 02

    Support

    OralPath provides decision-support context without replacing clinical judgement.

  3. 03

    Safeguard

    Guideline-aware safeguards sit around the product experience.

  4. 04

    Govern

    Clinical safety, auditability and deployment evidence are part of the programme.

  5. 05

    Sign

    The responsible clinician remains accountable for the final decision.

Designed for triage

Product-market fit without exposing the product map.

OralPath is positioned for clinical triage environments where oral mucosal lesion review needs better structure, safety and governance. Detailed workflow design is shared only with appropriate partners.

Oral mucosal lesions GDP front door GP triage OMFS review Referral support Audit trail
Pathway logic Clinician controlled
Image

Clinical material reviewed in context

Context

Relevant information held together

Safety

Guideline-aware safeguards

Decision

Clinician review and sign-off

Public preview intentionally limited
Safety by design

Clinical judgement stays in charge.

Not diagnostic

Triage support only

OralPath supports triage review. It does not diagnose oral cancer.

Guideline-aware

Safety safeguards

Safety boundaries are part of the product programme, with details reserved for partner contexts.

Clinician sign-off

Human accountability

The responsible clinician reviews the full context and signs the referral decision.

In clinical validation

Evidence before claims

OralPath is built and undergoing clinical validation; safety and performance evidence is published as it reads out (2026/27).

FAQ

Questions from clinical teams.

OralPath is available for guided demos with appropriate NHS and dental teams. Public materials intentionally avoid product implementation detail.

What is OralPath?+

OralPath is clinician-in-the-loop AI triage support for oral mucosal lesions. It is built to support safer clinical review without replacing clinician judgement.

Does OralPath diagnose oral cancer?+

No. It is not a diagnosis and does not replace the clinician. It surfaces risk and pathway support for review and sign-off.

Do you publish the product logic?+

No. Public materials describe positioning, safety boundaries and clinical context only. Detailed workflow and implementation details are shared only in appropriate demo or partner contexts.

Who is OralPath for?+

It is being developed for clinical teams where oral mucosal lesion review needs better structure, safety and auditability.

How can we see it?+

Request a guided demo through the booking page or email cs@csong.health with your organisation and role. Please do not send patient-identifiable data.

Design partners

Review OralPath in a controlled demo.

Appropriate clinical teams can review the product in context without public disclosure of product logic or implementation detail.